Professor Anthony Schapira was appointed Chairman of the University Department of Clinical Neurosciences at the UCL Queen Square Institute of Neurology and professor of neurology at the National Hospital for Neurology and Neurosurgery and the Royal Free Hospital, London, in 1990. He is currently chair of UCL’s department of clinical and movement neurosciences. He studies the molecular and clinical aspects of Parkinson’s disease (PD) and other movement disorders. He leads a large basic science and clinical translation program on glucocerebrosidase in PD. He has more than 450 peer-reviewed publications with a H-index of 97 (Web of Science) and is on the 2018 list of the world’s most Highly Cited Researchers (Clarivate). He was elected a Fellow of the Academy of Medical Sciences in 1999 and appointed a senior investigator at the National Institutes of Health Research in 2012. He was Editor-in-Chief of the European Journal of Neurology (2006 to 2019).
Associated Grants
-
(SUPPLEMENT) Examining How Genes and Gut Bacteria Cooperate to Cause Parkinson’s Disease
2023
-
-
Use of Novel Intestinal Imaging for Early Identification of Parkinson’s Disease and Assessment of Response to Therapies that Reduce Alpha-synuclein Accumulation
2022
-
The Genome-Microbiome Axis in the Cause of Parkinson Disease: Mechanistic Insights and Therapeutic Implications from Experimental Models and a Genetically Stratified Patient Population
2020